UBS Initiates Coverage on Edwards Lifesciences (EW) with a Neutral
EW Hot Sheet
Rating Summary:12 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
UBS initiates coverage on Edwards Lifesciences (NYSE: EW) with a Neutral rating.
To see more analyst ratings on EW Click Here.
Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat cardiovascular disease.
To see more analyst ratings on EW Click Here.
Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat cardiovascular disease.
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- Wunderlich Securities Starts Mission West Properties (MSW) at Buy
- Wunderlich Securities Starts United Stationers (USTR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
